MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Acam2000 | |
New | Air Liquide Australia Limited Carbon Dioxide | |
New | Allertine | |
New | Aplicare 10% Sterile Povidone-Iodine | |
New | BCG Vaccine AJV | |
New | Benzylpenicillin Sodium Injection (Genus Pharmaceuticals) | |
New | Berocca Focus | |
New | Canesten Vaginal pH Self Test | |
New | Cidofovir Injection (Heritage) | |
New | Dexmedetomidine Medsurge | |
New | Elevit Breastfeeding | |
New | Murine Red Eyes | |
New | Ngenla | |
New | Oxybutynin Chloride Tablets, USP (Novitium Pharma LLC-USA) | |
New | Oxybutynin Hydrochloride Tablets (Morningside) | |
New | Sitagliptin Sandoz Pharma | |
New | Supremine ER | |
New | Tepmetko | |
New | Thiotepa-Reach | |
New | Vumerity | |
New | Xenetix | |
New | Xylanaest 1% with Epinephrine (Gebro Pharma) | |
Revised | Abilify Maintena | Adverse Effects (Undesirable Effects) |
Revised | Advantan | TGA Date |
Revised | Amipride 400 | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Antabuse | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Amisulpride | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APO-Desvenlafaxine MR | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Ezetimibe/Simvastatin | Adverse Effects (Undesirable Effects), Dose and Method of Administration |
Revised | APO-Lamotrigine | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Apomine Intermittent | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Shelf Life, Special Warnings and Precautions for Use |
Revised | Apomine Solution for Infusion | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Perindopril Arginine | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Teriflunomide | TGA Date |
Revised | APX-Escitalopram | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Aspen Ciprofloxacin Injection for Intravenous Infusion | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Azacitidine MSN | Dose and Method of Administration, Fertility, Pregnancy and Lactation |
Revised | Bortezomib Accord | Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Brufen Plus 200/12.8 | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Bupivadren | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Caelyx | List of Excipients, Nature and Contents of Container |
Revised | Capecitabine Sandoz | Special Warnings and Precautions for Use |
Revised | Carvedilol Sandoz | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Caspofungin AN | TGA Date |
Revised | Chemists' Own Anti-Inflammatory Pain Relief 25 Liquid Capsules | TGA Date |
Revised | Cilicaine V | List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Cizinate | TGA Date |
Revised | Clofen | Nature and Contents of Container, Overdose |
Revised | Coralan | TGA Date |
Revised | Cosentyx | Adverse Effects (Undesirable Effects) |
Revised | Cystadane | TGA Date |
Revised | DBL Fluorouracil Injection BP | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | DBL Pentamidine Isethionate for Injection | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | DBL Sulfamethoxazole 400 mg and Trimethoprim 80 mg Concentrate Injection BP | Fertility, Pregnancy and Lactation, Overdose |
Revised | Diamox | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Dicarz | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Dificid | Nature and Contents of Container |
Revised | Dilaudid, Dilaudid-HP injections | TGA Date |
Revised | Dizole | Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Pharmaceutical Form |
Revised | Domion | TGA Date |
Revised | D-Penamine | Nature and Contents of Container, Special Precautions for Storage |
Revised | Duralock-C | Description, Dosage and Administration, Indications, Pharmacology, Precautions |
Revised | Eligard | TGA Date |
Revised | Endep | List of Excipients, Qualitative and Quantitative Composition |
Revised | Epilim | Pharmacological Properties |
Revised | Epirubicin Accord | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Erlyand | Adverse Effects (Undesirable Effects) |
Revised | Ertapenem Juno | TGA Date |
Revised | Ethical Nutrients St John's Wort | Qualitative and Quantitative Composition |
Revised | Fisamox | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Flucloxacillin Kabi | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Galantyl | List of Excipients, Nature and Contents of Container |
Revised | Gamine XR | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Gazyva | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | GTA-Amlodipine | TGA Date |
Revised | Hydrea | TGA Date |
Revised | Idaprex | TGA Date |
Revised | Idaprex Combi 4/1.25 | TGA Date |
Revised | Imdur | Product Name change |
Revised | Imrest | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Indosyl Combi 4/1.25 | TGA Date |
Revised | Indosyl Mono | TGA Date |
Revised | Insig | Adverse Effects (Undesirable Effects) |
Revised | Intralipid | Nature and Contents of Container |
Revised | Isordil | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Kesimpta | Special Precautions for Storage |
Revised | Kivexa | TGA Date |
Revised | Lacosam | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Therapeutic Indications |
Revised | Lacosamide ARX | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, Pharmacological Properties, Sponsor, Therapeutic Indications |
Revised | Lipiodol Ultra Fluid | TGA Date |
Revised | Logem | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Lonsurf | Sponsor |
Revised | Loxalate | Qualitative and Quantitative Composition |
Revised | Lucentis | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmaceutical Form |
Revised | Mekinist | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Metronidazole Kabi | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
Revised | MMA/PA Express 15 | Description, Dosage and Administration, Indications, Name of Medicine, Precautions, Presentation, Storage |
Revised | Molaxole | Nature and Contents of Container |
Revised | Monodur | Product Name change |
Revised | Myfortic | TGA Date |
Revised | Naloxone SXP | TGA Date |
Revised | Neo-B12 Injection | Adverse Effects (Undesirable Effects), Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Nexium Hp7 | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Nuvaxovid | Adverse Effects (Undesirable Effects) |
Revised | Opdivo | Pharmacological Properties |
Revised | Paxlovid | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions |
Revised | Paxtine | Nature and Contents of Container |
Revised | Perindo | TGA Date |
Revised | Perindo Combi 4/1.25 | TGA Date |
Revised | Phenergan | Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Piperacillin/Tazobactam Kabi | TGA Date |
Revised | Prolastin C Liquid | TGA Date |
Revised | Prolia | Nature and Contents of Container |
Revised | Prolistat | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines, New contraindication, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Reandron 1000 | TGA Date |
Revised | Remsima | Dose and Method of Administration, Pharmacological Properties |
Revised | Resonium A | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Pharmaceutical Form, Physicochemical Properties, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Rinvoq | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Sandoz Ibuprofen Plus Codeine | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Seasonique | Special Warnings and Precautions for Use |
Revised | Sleep Safe Balance | Adverse Effects (Undesirable Effects), List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition, Shelf Life |
Revised | Sodium Valproate Sandoz | Pharmacological Properties |
Revised | Soframycin Ear | List of Excipients, Special Warnings and Precautions for Use |
Revised | Soframycin Eye | List of Excipients, Special Warnings and Precautions for Use |
Revised | Sporanox Oral Solution | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Stay Safe Balance | Adverse Effects (Undesirable Effects), List of Excipients, Name of Medicine, Nature and Contents of Container, Qualitative and Quantitative Composition, Shelf Life |
Revised | Symbicort Turbuhaler | Nature and Contents of Container |
Revised | Tafinlar | Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Tamate | Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Tazac | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
Revised | Tecartus | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Timoptol | TGA Date |
Revised | Timoptol-XE | TGA Date |
Revised | Tobramycin Viatris | Product Name change |
Revised | Trizivir | TGA Date |
Revised | Trusopt | TGA Date |
Revised | Tryzan Caps | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Tryzan Tabs | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Valdoxan | TGA Date |
Revised | Vancocin Capsules | Qualitative and Quantitative Composition |
Revised | Vasodrine | TGA Date |
Revised | Velcade | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Vfend | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Pharmaceutical Form, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Vitalipid N | List of Excipients, Qualitative and Quantitative Composition |
Revised | Xelabine | List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition, Special Precautions for Storage |
Revised | Yescarta | Adverse Effects (Undesirable Effects) |
Revised | Zempreon CFC-Free Inhaler with Counter | Nature and Contents of Container |
Revised | Zithro | TGA Date |
Revised | Zyvox | Special Warnings and Precautions for Use |
Deleted | Amisolan | |
Deleted | APO-Doxycycline | |
Deleted | APOHealth Anti-Inflammatory Pain Relief Gel | |
Deleted | Cefaclor GH | |
Deleted | Celazadine | |
Deleted | Cisatracurium Accord | |
Deleted | CoPlavix | |
Deleted | Endura Energy Bar | |
Deleted | Endura Maintain | |
Deleted | Endura N-Acetyl Carnitine | |
Deleted | Endura N-Acetyl Carnitine Tablets | |
Deleted | Endura Overtraining Formula | |
Deleted | Endura P-Protein Shake | |
Deleted | Endura P-Protein Soup | |
Deleted | Endura Pro Body Bar | |
Deleted | Ethical Nutrients Super Multi | |
Deleted | Ethical Nutrients Super Multi Plus | |
Deleted | Famciclovir SCP | |
Deleted | Famotidine AN | |
Deleted | Frakas | |
Deleted | Herceptin | |
Deleted | Leflunomide AN | |
Deleted | Lopresor | |
Deleted | Momex SR | |
Deleted | Orencia 125 mg Solution for Injection Prefilled Pen (Germany) | |
Deleted | Pemetrexed Sandoz | |
Deleted | Pharmacor Esomeprazole | |
Deleted | ReddyMax Plus D-Cal | |
Deleted | Rosuvastatin Generichealth | |
Deleted | Sandoz Analgesic/Calmative |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au